1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Extracellular Matrix Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Extracellular Matrix Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Extracellular Matrix Market Regional Analysis
6.2 Europe Extracellular Matrix Market Revenue 2019-2028 (US$ Thousand)
6.3 Europe Extracellular Matrix Market Forecast Analysis
7. Europe Extracellular Matrix Market Analysis – by Raw Material
7.1 Bovine
- 7.1.1 Overview
- 7.1.2 Bovine: Europe Extracellular Matrix Market – Revenue and Forecast, 2019-2028 (US$ Thousand)
7.2 Porcine
- 7.2.1 Overview
- 7.2.2 Porcine: Europe Extracellular Matrix Market – Revenue and Forecast, 2019-2028 (US$ Thousand)
7.3 Other Raw Material
- 7.3.1 Overview
- 7.3.2 Other Raw Material: Europe Extracellular Matrix Market – Revenue and Forecast, 2019-2028 (US$ Thousand)
8. Europe Extracellular Matrix Market Analysis – by Application
8.1 Soft Tissue Repair
- 8.1.1 Overview
- 8.1.2 Soft Tissue Repair: Europe Extracellular Matrix Market – Revenue and Forecast, 2019-2028 (US$ Thousand)
8.2 Dural Repair
- 8.2.1 Overview
- 8.2.2 Dural Repair: Europe Extracellular Matrix Market – Revenue and Forecast, 2019-2028 (US$ Thousand)
8.3 Wound Healing
- 8.3.1 Overview
- 8.3.2 Wound Healing: Europe Extracellular Matrix Market – Revenue and Forecast, 2019-2028 (US$ Thousand)
8.4 Cardiac Repair
- 8.4.1 Overview
- 8.4.2 Cardiac Repair: Europe Extracellular Matrix Market – Revenue and Forecast, 2019-2028 (US$ Thousand)
8.5 Pericardial Repair
- 8.5.1 Overview
- 8.5.2 Pericardial Repair: Europe Extracellular Matrix Market – Revenue and Forecast, 2019-2028 (US$ Thousand)
8.6 Vascular Repair and Reconstruction
- 8.6.1 Overview
- 8.6.2 Vascular Repair and Reconstruction : Europe Extracellular Matrix Market – Revenue and Forecast, 2019-2028 (US$ Thousand)
9. Europe Extracellular Matrix Market – Europe Analysis
9.1 Overview
9.2 Europe
- 9.2.1 Europe Extracellular Matrix Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 9.2.1.1 Europe Extracellular Matrix Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 UK:
Europe Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
- 9.2.1.1.1 UK: Europe Extracellular Matrix Market Breakdown, by Raw Material
- 9.2.1.1.2 UK: Europe Extracellular Matrix Market Breakdown, by Application
- 9.2.1.2 Germany:
Europe Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
- 9.2.1.2.1 Germany: Europe Extracellular Matrix Market Breakdown, by Raw Material
- 9.2.1.2.2 Germany: Europe Extracellular Matrix Market Breakdown, by Application
- 9.2.1.3 France:
Europe Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
- 9.2.1.3.1 France: Europe Extracellular Matrix Market Breakdown, by Raw Material
- 9.2.1.3.2 France: Europe Extracellular Matrix Market Breakdown, by Application
- 9.2.1.4 Russia:
Europe Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
- 9.2.1.4.1 Russia: Europe Extracellular Matrix Market Breakdown, by Raw Material
- 9.2.1.4.2 Russia: Europe Extracellular Matrix Market Breakdown, by Application
- 9.2.1.5 Italy:
Europe Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
- 9.2.1.5.1 Italy: Europe Extracellular Matrix Market Breakdown, by Raw Material
- 9.2.1.5.2 Italy: Europe Extracellular Matrix Market Breakdown, by Application
- 9.2.1.6 Rest of Europe:
Europe Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
- 9.2.1.6.1 Rest of Europe: Europe Extracellular Matrix Market Breakdown, by Raw Material
- 9.2.1.6.2 Rest of Europe: Europe Extracellular Matrix Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Medtronic
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Merck Kgaa
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Smith & Nephew
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Anteris
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Coloplast Group
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Baxter
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 DSM
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Cook Biotech
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations